Today's New Buy Pick - Kadmon Holdings, Inc. (KDMN)

[Retire In 18 Months With $2.4 Million?]( [Too good to be true? Not for this 37 year old stock trader](. [See His Story]( __________________________________________________ [Tesla]( shares are up more than 12% today after rising 19.9% on Monday, its biggest one-day gain in six years, surging above $900 in early trading this morning. Major shareholder Ron Baron said yesterday that the electric vehicle maker will top $1 trillion in revenue in a decade, while ARK Invest—Tesla’s biggest bull—forecast that shares will be worth $7,000 by 2024, 737% higher than the price as of this writing... Anavex Life Sciences (NASDAQ: [AVXL]( Shares of this clinical-stage biopharmaceuticals stock jumped as much as 18% yesterday after it announced that the FDA had granted a Fast Track designation for ANAVEX 2.73 for the treatment of the genetic brain disorder Rett syndrome. “With no currently approved agents to treat Rett syndrome, patients and their physicians have an urgent need for new therapeutic options... [Read More]( [[On Camera] Retired Millionaire Leaves South America to Make Shocking Gold Prediction]( Legendary investor Doug Casey just made a MASSIVE gold prediction... It’s so outrageous, it nearly wasn't published. But then he agreed to make it official and go on camera for an exclusive interview. And what he said is shocking… Doug calls it the "most bullish sign [he’s] seen in 45 years…" If you’re interested, the full interview is available free for a short time. (ad) [Watch the Interview Now]( [Former Hedge Fund Manager: "Get out of Cash on this day in Feb"]( February 12th, 2020 could kick off the most profitable year we've seen in the last two decades in the stock market. But only if you put your money into a short list of stocks - immediately. (ad) [If you think you've missed out on the biggest gains this bull market has to offer, click here to for everything you need to get ready for February 12th.]( [WLK is down -15% in the last three weeks – it might be a better buy now than ever]( While a lot of investors are wringing their hands and fretting about what the near-term future of the market is going to be, the truth is that market corrections tend to be healthy in the long-term. It is true that the market could move beyond the corrective stage into a long-anticipated and much-feared bear market. [Read More]( [You Could Make $300 to $1100 Per Contract With This Simple Trade]( - Imagine getting really good at mastering just ONE simple trade. A trade that appears like clockwork between 9:30-10:45am on most trading days. This free step-by-step guide, by options expert, Dave Acquino, shows you how to spot and take these trades so you can walk away with daily profits! (ad) [CLICK HERE for instant access.]( Featured Stock [Kadmon Holdings, Inc. (KDMN) – Buy Target – $5.15 or better]( Kadmon Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases. The company markets and distributes products in various therapeutic areas, including ribavirin products for chronic hepatitis C virus infection; and distributes products in various therapeutic areas. Other Top Stories [US stocks open broadly higher following gains in China]( [Royal Caribbean takes steps to contend with virus outbreak]( [Changing counts reveal inexact science of calorie labels]( [Ferrari reports 11% profit drop last year but raises outlook]( Sponsor [Your FREE Book is Waiting to Be Claimed...]( Income expert Neil George has just released a new book called Income for Life. Inside, it details more than 65 little-known income streams that ANYONE can collect. However, this book is not available for sale. Instead, we're on a nationwide campaign to spread the book far and wide for FREE. [Click here to learn how to claim a copy.]( Trend Following Picks [(MTEM) – Buy Target – $15.50 or better]( [(CNNE) – Buy Target – $41.00 or better]( [(MLSS) – Buy Target – $1.80 or better]( [(CLSD) – Buy Target – $3.30 or better]( [(CDTX) Buy Target – $4.25 or better]( [All Picks]( Reversal Picks [(EMMS) Buy Target $4.08 Sell Target $4.43]( [(DCIX) Buy Target $0.87 Sell Target $0.95]( [(AKTX) Buy Target $2.05 Sell Target $2.28]( [(AQMS) Buy Target $0.96 Sell Target $1.29]( [(SPRO) Buy Target $10.16 Sell Target $11.04]( [All Picks]( Already subscribed to our premium service? [Click here to Login](. Not a TradersPro subscriber yet? [Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits]( --------------------------------------------------------------- This email was sent to {EMAIL} by Investiv, LLC 265 N. Main | Ste. D #283 | Kaysville | UT | 84037 [Forward to a friend]( | [Unsubscribe]( or [Mange which emails you get from TradersPro]( Disclaimers Investing is Inherently Risky There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Hypothetical Results Are Reported Results and examples used in the Company’s advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage. The Company’s simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company’s software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified. Offers Disinterested Commentary and Analysis The Company does not receive any form of payment or other compensation for publishing information, news, research, or any other material concerning specific securities on the Network that is intended to affect or influence the value of securities. The Company, and its personnel, do not engage in front-running of recommendations and do not trade against one’s own recommendations. The Company and its management may benefit from an increase or decrease in the share prices of the profiled companies, and/or may have other actual or potential conflicts of interest. If a particular security featured in a newsletter publication is concurrently owned by the Company in its corporate brokerage account, or in any of the individual accounts of the Company’s principals or analysts / writers, that fact will be disclosed. The Company, its principals, analysts and writers may choose to purchase a security or derivative featured in one of its newsletter publications, but typically will wait three (3) trading days from the date of publication before initiating said purchase. [Disclaimers, Terms & Conditions]( | [Privacy Policy]( Copyright © 2019